comparemela.com
Home
Live Updates
Angiocrine Bioscience Announces it has been awarded a $15M G
Angiocrine Bioscience Announces it has been awarded a $15M G
Angiocrine Bioscience Announces it has been awarded a $15M Grant from the California Institute for Regenerative Medicine for AB-205 Phase 3 Clinical Trial
/PRNewswire/ -- Angiocrine Bioscience, Inc., a clinical-stage biopharmaceutical company today announced that the California Institute for Regeneration Medicine...
Related Keywords
California ,
United States ,
American ,
Mariat Millan ,
Paul Finnegan ,
Angiocrine Bioscience ,
Prnewswire Angiocrine Bioscience Inc ,
National Institute Of Health Clinicaltrials ,
California Institute For Regeneration Medicine ,
Drug Administration ,
Angiocrine Bioscience Inc ,
American Cancer Society ,
California Institute ,
Regeneration Medicine ,
Regenerative Medicine Advanced Therapy ,
Orphan Drug ,
Advanced Reparative Medicine ,
National Institute ,
Advanced Reparative Medicines ,
Nc ,